Literature DB >> 26447135

Dysregulated apoptosis of the venous wall in chronic venous disease and portal hypertension.

Li Kun1, Li Ying1, Wang Lei2, Zhao Jianhua1, Xu Yongbo1, Wang Tao3, Tang Jinyuan1, Chu Haibo1.   

Abstract

Introduction The etiology of varicose veins remains elusive. We hypothesized that abnormal cell cycle events in the vein wall may contribute to changes in the structural integrity, thus predisposing to the development of varicosities. The present study was designed to determine whether or not the same molecular apoptotic pathway exists between great saphenous and splenic veins. Methods Thirty-six samples of diseased splenic veins and varicose great saphenous veins were collected. Twenty-five samples of control splenic and great saphenous veins were also collected. The apoptotic cell proteins expression was immunohistochemically stained with antibodies (anti-Bax and anti-Bcl-xl). Apoptosis was evaluated by the terminal deoxynucleotidyl transferase-mediated nick-end labeling (TUNEL) assay and immunofluorescence staining. The morphology of apoptotic cells was observed with an electron microscope. Results The apoptotic ratio in walls (intima and media) of diseased splenic vein and varicose great saphenous vein groups were significantly lower than the corresponding regions in the splenic vein and great saphenous vein groups ( p < 0.01), respectively. A significant difference was not noted in the ratio change of apoptotic cells between the diseased splenic vein and varicose great saphenous vein groups ( p > 0.05). The high positive expression of Bcl-xl proteins was detected in the diseased splenic vein and varicose great saphenous vein groups, respectively. While the high positive expression of Bax proteins was also observed in the splenic vein and great saphenous vein groups, respectively. Electron microscopic observations confirmed that endothelial and smooth muscle cells in diseased splenic vein, varicose great saphenous vein, splenic vein, and great saphenous vein walls exhibited apoptotic morphologic features, such as fuzzy mitochondrial cristae, medullary changes, and margination of the nuclear chromatin. Conclusions Our results showed the same dysregulation of apoptosis via the intrinsic pathway in diseased splenic veins and varicose great saphenous veins. This observational study suggests that apoptotic down-regulation in the veins wall is a cause of diseased splenic veins and varicose great saphenous veins, but does not exclude the possibility that other mechanisms are involved.

Entities:  

Keywords:  Varicose vein; apoptosis; diseased splenic vein; vascular remodeling

Mesh:

Substances:

Year:  2016        PMID: 26447135     DOI: 10.1177/0268355515610237

Source DB:  PubMed          Journal:  Phlebology        ISSN: 0268-3555            Impact factor:   1.740


  4 in total

1.  Flow cytometric characterization of the saphenous veins endothelial cells in patients with chronic venous disease and in patients undergoing bypass surgery: an exploratory study.

Authors:  Cláudia Torres; Rui Machado; Margarida Lima
Journal:  Heart Vessels       Date:  2019-06-21       Impact factor: 2.037

2.  TMEM16A regulates portal vein smooth muscle cell proliferation in portal hypertension.

Authors:  Xi Zeng; Ping Huang; Mingkai Chen; Shiqian Liu; Nannan Wu; Fang Wang; Jing Zhang
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.447

3.  Efficacy and safety of Buyang Huanwu decoction in the treatment of varicose veins of the lower extremities: A protocol of randomized controlled trial.

Authors:  Chuanyong Li; Weijian Fan; Zhichang Pan; Guangfeng Zheng; Qiang Zhang; Jianjie Rong
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

Review 4.  The aging venous system: from varicosities to vascular cognitive impairment.

Authors:  Andrea Ágnes Molnár; György László Nádasy; Gabriella Dörnyei; Bernadett Bettina Patai; Jordan Delfavero; Gábor Áron Fülöp; Angelia C Kirkpatrick; Zoltán Ungvári; Béla Merkely
Journal:  Geroscience       Date:  2021-11-11       Impact factor: 7.713

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.